796967-18-5

Basic information

• Product Name: Urea, N-(2-fluoro-5-Methylphenyl)-N'-[4-(4,4,5,5-tetraMethyl-1,3,2-dioxaborola n-2-yl)phenyl]-
• Synonyms: Urea, N-(2-fluoro-5-Methylphenyl)-N'-[4-(4,4,5,5-tetraMethyl-1,3,2-dioxaborola n-2-yl)phenyl]-;N-(2-Fluoro-5-methylphenyl)-N'-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]urea;N-(2-fluoro-5-Methylphenyl)-N'-[4-(4,4,5,5-tetraMethyl-1,3,2-dioxaborola n-2-yl)phenyl]-
• CAS NO: 796967-18-5
• Molecular Formula: C₂₀H₂₄BFN₂O₃
• Molecular Weight: 370.2255632
• EINECS: -0
• Mol File: 796967-18-5.mol
• Article Data: 11

Chemical Properties

• Appearance: /
• Density: 1.18
• Storage Temp.: 2-8°C
• CAS DataBase Reference: Urea, N-(2-fluoro-5-Methylphenyl)-N'-[4-(4,4,5,5-tetraMethyl-1,3,2-dioxaborola n-2-yl)phenyl]-(CAS DataBase Reference)
• NIST Chemistry Reference: Urea, N-(2-fluoro-5-Methylphenyl)-N'-[4-(4,4,5,5-tetraMethyl-1,3,2-dioxaborola n-2-yl)phenyl]-(796967-18-5)
• EPA Substance Registry System: Urea, N-(2-fluoro-5-Methylphenyl)-N'-[4-(4,4,5,5-tetraMethyl-1,3,2-dioxaborola n-2-yl)phenyl]-(796967-18-5)

Safety Data

• Hazardous Substances Data: 796967-18-5(Hazardous Substances Data)

Usage

General Description

Urea, N-(2-fluoro-5-Methylphenyl)-N'-[4-(4,4,5,5-tetraMethyl-1,3,2-dioxaborola n-2-yl)phenyl]- is a chemical compound with a complex structure. It contains urea and boron components, as well as a fluoro-Methylphenyl group and a tetraMethyl group. Urea, N-(2-fluoro-5-Methylphenyl)-N'-[4-(4,4,5,5-tetraMethyl-1,3,2-dioxaborola n-2-yl)phenyl]- may have various industrial uses, such as in organic synthesis or as a reagent in chemical reactions. Its specific properties and applications would depend on its precise molecular structure and reactivity. Further research and testing would be necessary to fully understand its potential uses and effects.

Upstream product

• 73183-34-3 bis(pinacol)diborane 
• 452-84-6 3-amino-4-fluorotoluene 
• 214360-73-3 4-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)aniline 
• 106-40-1 4-bromo-aniline 

Downstream Products

• 796967-16-3 linifanib 
• 819058-30-5 C₂₁H₁₇FN₄OS 

Relevant articles and documents

UREA INHIBITORS OF MICRO-RNA

The present disclosure relates to compounds and methods which may be useful as inhibitors of the expression of miRNA, for use in the treatment or prevention of cancer.

Novel Hydroximic Acid Derivative and Medical Application Thereof

The present invention relates to a kind of new hydroximic acid derivatives, in particular, hydroximic acid derivatives of pyrazolopyrimidine and their medical applications, which have inhibition to histone deacetylase 1 and two kinds of tyrosine kinases (vascular endothelial cell growth factor receptors as well as platelet-derived growth factor receptors) simultaneously, and thus can be used for treatment of diseases related to those three kinds of enzymes. This kind of compounds both exerts a synergistic effect sufficiently to increase biological activity, and avoids problems caused by different properties and metabolisms, therefore is more practical and has good prospects.

UREA DERIVATIVES AND USES THEREOF

The present invention provides novel compounds of any one of Formulae (I)-(III), and pharmaceutical compositions thereof. Also provided are particles (e.g., nanoparticles) comprising compounds of Formula (I)-(III) and pharmaceutical compositions thereof that are mucus penetrating. The invention also provides methods and kits for using the inventive compounds, and pharmaceutical compositions thereof, for treating and/or preventing diseases associated with abnormal or pathological angiogenesis and/or aberrant signaling of a growth factor (e.g., vascular endothelial growth factor (VEGF)), such as proliferative diseases (e.g., cancers, benign neoplasms, inflammatory diseases, autoimmune diseases) and ocular diseases (e.g., macular degeneration, glaucoma, diabetic retinopathy, retinoblastoma, edema, uveitis, dry eye, blepharitis, and post-surgical inflammation) in a subject in need thereof.